Trials / Completed
CompletedNCT03226951
SDM Laser for Non Central Diabetic CSME
Sub Threshold Laser for Non Central Diabetic Clinical Significant Macular Edema
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Marashi Eye Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Is to determine if SDM laser can reduce macular thickness in non central CSME and stop the progression of non central CSME to central CSME in compare to glycemic control
Detailed description
interventional randomised masked study will recruit patients have diabetes mellitus with non central CSME with good vision into two groups : 1st SDM laser with glycemic control 2nd SHAM laser with Glycemic control where BCVA will be recorded every month starting from baseline to 24 weeks where OCT will be recorded every 8 weeks from baseline to 24 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Subthreshold 532nm laser | Subthershold 532nm laser |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2018-01-31
- Completion
- 2018-02-01
- First posted
- 2017-07-24
- Last updated
- 2018-10-29
Locations
1 site across 1 country: Syria
Source: ClinicalTrials.gov record NCT03226951. Inclusion in this directory is not an endorsement.